EpCAM
Journal
Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127
Informations de publication
Date de publication:
2019
2019
Historique:
received:
03
05
2019
revised:
06
09
2019
accepted:
11
09
2019
entrez:
23
10
2019
pubmed:
23
10
2019
medline:
17
4
2020
Statut:
epublish
Résumé
The CellSearch® system which is still considered the gold standard for the enumeration of circulating tumor cells (CTC) utilizes antibodies against the epithelial cell adhesion molecule (EpCAM) for CTC enrichment. Recently, CTC discarded by the CellSearch® system due to their low EpCAM expression have been isolated and analyzed. We here sought to discuss technical and biological issues concerning the isolation and characterization of EpCAM
Identifiants
pubmed: 31636732
doi: 10.1155/2019/1718920
pmc: PMC6766153
doi:
Substances chimiques
Antigens, Neoplasm
0
Biomarkers, Tumor
0
Epithelial Cell Adhesion Molecule
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1718920Informations de copyright
Copyright © 2019 Chiara Nicolazzo et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest regarding the publication of this paper.
Références
Gynecol Oncol. 2018 Feb;148(2):383-392
pubmed: 29208367
Cell Mol Life Sci. 2014 Nov;71(22):4393-402
pubmed: 25103341
Breast Cancer Res. 2014 Mar 06;16(2):R23
pubmed: 24602188
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Clin Cancer Res. 2004 Oct 15;10(20):6897-904
pubmed: 15501967
Biochemistry (Mosc). 2018 Dec;83(12):1469-1476
pubmed: 30878022
Adv Drug Deliv Rev. 2018 Feb 1;125:102-121
pubmed: 29355669
Annu Rev Cancer Biol. 2018 Mar;2:271-289
pubmed: 29756093
Int J Cancer. 2011 Jul 15;129(2):417-23
pubmed: 20857493
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):151-157
pubmed: 29997040
Cancer Res. 2013 Apr 1;73(7):2059-69
pubmed: 23378342
Cancer Biol Ther. 2014 May;15(5):496-503
pubmed: 24521660
Int J Mol Sci. 2016 Oct 24;17(10):
pubmed: 27783057
Cancers (Basel). 2018 Dec 19;10(12):null
pubmed: 30572662
Genes Dev. 2017 Sep 15;31(18):1827-1840
pubmed: 29051388
Urology. 2001 Sep;58(3):386-92
pubmed: 11549486
Int J Cancer. 2012 Feb 15;130(4):808-16
pubmed: 21387303
Mol Oncol. 2016 Mar;10(3):395-407
pubmed: 26795350
Sci Rep. 2015 Jul 17;5:12270
pubmed: 26184843
Laryngoscope Investig Otolaryngol. 2017 May 20;2(4):194-198
pubmed: 28894840
Breast Cancer Res. 2009;11(4):R46
pubmed: 19589136
Nature. 2015 Nov 26;527(7579):472-6
pubmed: 26560033
Curr Opin Cell Biol. 2016 Dec;43:7-13
pubmed: 27371787
Chin J Cancer Res. 2015 Oct;27(5):491-6
pubmed: 26543336
Chin J Cancer Res. 2018 Dec;30(6):596-604
pubmed: 30700928
Ther Adv Med Oncol. 2010 Nov;2(6):351-65
pubmed: 21789147
Oncotarget. 2018 Nov 2;9(86):35705-35716
pubmed: 30479699
Int J Cancer. 2019 Jun 15;144(12):3127-3137
pubmed: 30536653
Cancer Res. 2015 Sep 1;75(17):3636-49
pubmed: 26141860
BMC Cancer. 2015 Mar 31;15:206
pubmed: 25884197
Ann Oncol. 2011 Aug;22(8):1929-30
pubmed: 21633048
Expert Rev Mol Diagn. 2016 Dec;16(12):1291-1305
pubmed: 27797592
Nat Rev Urol. 2017 Feb;14(2):90-97
pubmed: 27872478
Methods Mol Biol. 2015;1347:263-78
pubmed: 26374323
Int J Biol Markers. 2017 Oct 31;32(4):e415-e420
pubmed: 28604994
Urology. 2018 May;115:82-86
pubmed: 29432873
Biomark Res. 2018 Oct 30;6:31
pubmed: 30450210